Amiodarone Inhibits the Production of Tumor Necrosis Factor-Α:A Study of the Prevention Value on Sundden Death in Heart Failure Patients

王志坚,杭娟,蒋宝琦,陈赛勇

DOI: https://doi.org/10.3969/j.issn.1672-5301.2008.11.002

2008-01-01

Abstract:Objective To observe the inhibition effect of amiodarone on the production of tumore necrosis factor-α( TNF-α) secreted by peripheral blood monouclear cells( PBMC) in heart failure patients.Methods 160 patients with chronic heart falure were enrolled and randomly assigned to amoidarone group ( conventional therapy + amoidarone,200 mg daily,n =80) and control group ( conventional therapy +placebo,n =80).After evaluation of baseline characteristics,patients in amoidarone group received amiodarone tablets for 2 years,while control group maintained conventional therapy.Primary endpoint was all-cause mortality.Secondary endpoint consists of ( a) sud- den death,( b) the change of left ventricular ejection fraction ( LVEF) and TNF-α concentration.Results Com- pared with control group,the mortality risk was 29% lower in amiodarone group ( 95% CI 5%-45%,P=0.025),the risk ratio of sudden death was 32% lower ( 95% CI,11%-48%,P=0.016),and the rehospitalization risk ratio was 39% lower ( 95% CI 14%-49%,P=0.0027).Amiodarone significantly increased the LVEF level of heart fail- ure patients ( P0.01) and inhibited the TNF-α concentration ( P0.01),wherein LVEF is negatively correlated with the TNF-α concentration( r=0.31,P0.01).Conclusion By inhibiting the production of TNF-α secreted by PBMC,amoidarone improves the heart function and decreases mortality and morbidity in heart failure patients.